Exagen (XGN) EPS (Weighted Average and Diluted) (2020 - 2026)
Exagen (XGN) reported EPS (Weighted Average and Diluted) of -$0.17 for Q1 2026, up 15.0% on a YoY basis from -$0.15 in Q1 2025, and up 15.0% quarter-over-quarter from -$0.2 in Q4 2025.
Exagen (XGN) EPS (Weighted Average and Diluted) (2020 - 2026) Analysis & Trends
Exagen has reported EPS (Weighted Average and Diluted) for 7 years, with the latest figure at -$0.17 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 15.0% year-over-year to -$0.17; the trailing twelve-month figure through Mar 2026 stood at -$0.89 (down 5.95% YoY), and the FY2025 full-year result was -$0.93, down 12.05% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.17, up from -$0.2 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was -$0.16 in Q2 2024, with the low at -$0.86 in Q2 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.35 across 5 years, with a median of -$0.28 in 2023.
- Annual changes were most pronounced in 2022 — EPS (Weighted Average and Diluted) slumped 126.32% — and 2023, when it soared 67.44%.
- Exagen's EPS (Weighted Average and Diluted) stood at -$0.83 in 2022, then soared by 62.65% to -$0.31 in 2023, then jumped by 35.48% to -$0.2 in 2024, then declined by 0.0% to -$0.2 in 2025, then rose by 15.0% to -$0.17 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.17 (Q1 2026), -$0.2 (Q4 2025), and -$0.31 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -0.87 |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 4.43 |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 1.45 |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 3.47 |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 1.20 |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 1.61 |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -0.60 |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 0.87 |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 8.33 |
| 10 | Exagen | 101.38 Mn | 79.87 Mn | 10.21 Mn | -0.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.17 |
| Dec 31, 2025 | -0.20 |
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -0.21 |
| Mar 31, 2025 | -0.20 |
| Dec 31, 2024 | -0.20 |
| Sep 30, 2024 | -0.28 |
| Jun 30, 2024 | -0.16 |
| Mar 31, 2024 | -0.19 |
| Dec 31, 2023 | -0.31 |
| Sep 30, 2023 | -0.31 |
| Jun 30, 2023 | -0.28 |
| Mar 31, 2023 | -0.44 |
| Dec 31, 2022 | -0.83 |
| Sep 30, 2022 | -0.47 |
| Jun 30, 2022 | -0.86 |
| Mar 31, 2022 | -0.60 |
| Dec 31, 2021 | -0.41 |
| Sep 30, 2021 | -0.42 |
| Jun 30, 2021 | -0.38 |